Comparing cardiovascular adverse events in cancer patients: A meta-analysis of combination therapy with angiogenesis inhibitors and immune checkpoint inhibitors versus angiogenesis inhibitors aloneFelice Crocetto, Giuseppe Di Lorenzo, Matteo Ferro et al.|Critical Reviews in Oncology/Hematology|2023Cited by 36
Crosslink between atrial fibrillation and cancer: a therapeutic conundrumErmanno Nardi, Giovanni Esposito, Stefania Paolillo et al.|Cardio-Oncology|2024Cited by 2